Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder

Lucy K. Martin; Paolo Romanelli; Yeon Soong Ahn; Robert S. Kirsner

doi:10.1111/j.1365-4632.2004.02249.x

Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder

Lucy K. Martin, Paolo Romanelli, Yeon Soong Ahn, Robert S. Kirsner

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.

Original language	English (US)
Pages (from-to)	922-924
Number of pages	3
Journal	International journal of dermatology
Volume	43
Issue number	12
DOIs	https://doi.org/10.1111/j.1365-4632.2004.02249.x
State	Published - Dec 1 2004

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/j.1365-4632.2004.02249.x

Fingerprint Dive into the research topics of 'Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder'. Together they form a unique fingerprint.

Cite this

@article{b3d52877ed5e4f5796cdbc14065a621f,

title = "Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder",

abstract = "Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.",

author = "Martin, {Lucy K.} and Paolo Romanelli and Ahn, {Yeon Soong} and Kirsner, {Robert S.}",

year = "2004",

month = dec,

day = "1",

doi = "10.1111/j.1365-4632.2004.02249.x",

language = "English (US)",

volume = "43",

pages = "922--924",

journal = "International Journal of Dermatology",

issn = "0011-9059",

publisher = "Wiley-Blackwell",

number = "12",

}

TY - JOUR

T1 - Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder

AU - Martin, Lucy K.

AU - Romanelli, Paolo

AU - Ahn, Yeon Soong

AU - Kirsner, Robert S.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.

AB - Telangiectasia macularis eruptiva perstans (TMEP) is a cutaneous form of mastocytosis. It has been rarely associated with an underlying myeloproliferative disorder. We report the case of a patient, while receiving treatment for thrombocytosis, with both platelet production and function inhibitors presented with TMEP. TMEP is often refractory to therapy; however, our patient responded to treatment with PUVA.

UR - http://www.scopus.com/inward/record.url?scp=10444265209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10444265209&partnerID=8YFLogxK

U2 - 10.1111/j.1365-4632.2004.02249.x

DO - 10.1111/j.1365-4632.2004.02249.x

M3 - Article

C2 - 15569020

AN - SCOPUS:10444265209

VL - 43

SP - 922

EP - 924

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 12

ER -